Dear ALF Friend, This past year was another transformational year for American Liver Foundation (ALF). Building upon the growth, learnings and successes of 2021, we went into 2022 with a comprehensive plan focused on improving patient lives, increasing public awareness of liver disease and advancing early diagnosis, new treatments and cures. A few highlights you will learn more about in the pages that follow include: Launching our five-year nationwide public health initiative, Think Liver Think Life™, in the first ten states, which created hundreds of new partnerships and screening opportunities. Our goal is to ensure that every American understands their risk for liver disease, receives the appropriate diagnostic testing and care coordination and feels well-informed and supported throughout their liver journey. Extending our reach by collaborating with organizations such as the American Diabetes Association (ADA) and Meijer Specialty Pharmacy to bring awareness to liver disease and its relationship to other health conditions such as obesity and diabetes. Creating a "Life with Biliary Atresia (BA) and Beyond" Facebook Support Group for pediatric patients and their families, featuring a quarterly educational webinar series with experts in BA, nutrition and more. We hope you enjoy learning about the impact ALF made on the lives of the 100 million Americans affected by liver disease last year. As always, thank you for your continued support – it is only through the generosity of our donors that we are able to fulfill our mission and one day reach our goal of a world free from liver disease. Sincerely, Hosting Liver Life Walks and Liver Life Challenge events in-person at locations across the country, bringing back a sense of community among liver patients, friends, families and more. Launching a new brand and refreshed website to better serve our growing patient community. Advancing living donor liver transplant by convening new partnerships with thought leaders and experts in liver transplantation, patients and families to discuss a different approach to increasing the number of, and access to, living donor transplants, breaking down barriers, utilizing information learned from successes in living kidney transplantation and encouraging innovation.
Dan Weil Chair, National Board of Directors
Lorraine Stiehl Chief Executive Officer
Made with FlippingBook - Online catalogs